Air Canada stock was upgraded to buy with an $18.31 target. Click here to read ACDVF's update on earnings, resilient ...

Esperion Therapeutics stock remains a buy as strong drug franchises, growth, and global milestones outweigh risks. Learn more ...

FS KKR Capital reports Q3 results after a 30% stock drop and plans for a 2026 dividend cut, prompting renewed interest. Learn ...

During strongly trending bull markets, investors often overlook the importance of math in predicting forward returns.

Centrus has a profitable operating business with promising long-term prospects, but the valuation is far above the LEU's ...

T-Mobile is a top telecom pick for growth and dividends after a recent pullback. See why now could be a smart time to invest ...

Stock index futures jump on reports of Senate breakthrough to end shutdown. Taiwan Semi's October revenue rises 17% YoY, ...

The Ministry of Finance and State Taxation Administration of China recently announced changes to the gold market value-added ...

Opendoor pursues a turnaround with new management, scaling acquisitions and reducing spreads in a challenging housing market.

Alphabet (GOOG, GOOGL) has delivered stellar returns, driven by robust growth in Google Cloud and broad-based revenue ...

Cambium Networks rises on the Starlink partnership but faces declining revenue, inconsistent profits, and high debt. Check ...

Puma Biotechnology has one approved drug, strong cash, and is developing alisertib with key ALISCA trial readouts in 1H 2026.